May 2010

Dr. Nancy Stagliano, CEO, will present an update on Probodies at the PEGS meeting in Boston, MA on May 21, 2010.

October 2009

Dr. Nancy Stagliano, CEO, will present on Oct. 8, 2009 at the 3rd Annual Therapeutic Monoclonal Antibody Discovery conference in Boston, MA.

Dr. James West will present on Oct. 8 in Hanover, Germany at the PEGS Europe meeting.

May 2009

CytomX Therapeutics receives a second Phase I SBIR award from the NIH/NCI to discover and develop a Probody to the Epidermal Growth Factor Receptor (EGFR).

January 2009

CytomX Therapeutics to present at the PepTalk conference in Coronado, CA on January 13 and 16.

October 2008

Drs. Dennis Fenton and Gary Wilcox join CytomX’s Board of Directors.

August 2008

CytomX Therapeutics completes an Exclusive License Agreement with the University of California, Santa Barbara, to its core intellectual property.

July 2008

Dr. James West joins the company as Head of Research.

May 2008

CytomX Therapeutics receives a Phase I SBIR award from the NIH/NCI to further its work on anti-angiogenic peptides.

February 2008

CytomX Therapeutics, LLC is founded as a subsidiary of CytomX, LLC. Dr. Nancy Stagliano is appointed Chief Executive Officer.